ALCATEL-LUCENT-ENTERPRIS
Alcatel-Lucent Enterprise , a leading digital-age networking, communications and cloud solutions provider, is hosting its Connex21 global partner conference virtually between February 1-4, 2021. It is the latest in an extensive program of virtual events, after the company adapted its priorities to keep employees safe and maintain business continuity for partners and customers.
Over 2,100 Alcatel-Lucent Enterprise partners and industry analysts from all over the world have registered to attend the summit. Under the theme ‘Build 2 Last’, Connex21 will feature speakers including CEO Jack Chen and Rukmini Glanard, Executive Vice President Global Sales, Services and Marketing.
Jack and Rukmini will join other Alcatel-Lucent Enterprise business leaders to outline the company’s 2021 strategy, discuss core business objectives, explain the product roadmap, and explore the growth opportunities this year poses for the business and its international partners.
“Last year was very difficult for every one of us,” comments Jack Chen, CEO of Alcatel-Lucent Enterprise. “The current situation has changed the way we work, and some of these changes will become permanent. This crisis has highlighted the critical need for digital transformation. Digital technology is enabling businesses to generate revenue, retain staff, and survive in challenging conditions. Technology is helping us all to adapt and find ways to grow.”
Over the course of Connex21, executives at the company will host dedicated sessions to demonstrate the impact its innovations are having in vertical industries across the globe. Product specialists will present the Alcatel-Lucent Enterprise roadmap for new solutions designed to support partners in solving business issues and driving growth for customers. The business will also outline its plan to support its partner community in 2021 with Cloud, Network and Communications solutions designed for critical verticals such as Transportation, Healthcare, Education, Government and Hospitality.
“Alcatel-Lucent Enterprise has a long history of evolving with the times,” says Jack Chen. “We’ve had to adapt to address the needs of the enterprise successfully for over 100 years. Versatility is in our DNA and originates from our ability to embrace innovation. Our solutions help businesses grow, irrespective of the market conditions. Our partners believe in our vision to help organisations grow through innovation and, together, we work tirelessly to achieve it. We want to continue to build great relationships and solutions that will last long into the future.”
Alcatel-Lucent Enterprise has a strong ecosystem of 2,900 direct business partners all over the world. This helps the company achieve an effective international reach, with a local focus, for over 830,000 customers in 100 countries around the world.
About Alcatel-Lucent Enterprise
Alcatel-Lucent Enterprise delivers the customised technology experiences enterprises need to make everything connect.
ALE provides digital-age networking, communications and cloud solutions tailored to ensure customers’ success, with flexible business models in the cloud, on premises, and hybrid. All solutions have built-in security and limited environmental impact.
Over 100 years of innovation have made Alcatel-Lucent Enterprise a trusted advisor to more than 830,000 customers in 100 countries around the world.
The privately-owned company with headquarters in France has over 2,900 direct business partners worldwide, achieving an effective global reach with a local focus.
For more information: www.al-enterprise.com .
LinkedIn , Facebook , Twitter , Instagram .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210201005157/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom